ELASTATHERAPY

Serial Number 98391875
688

Registration Progress

Application Filed
Feb 5, 2024
Under Examination
Feb 4, 2025
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Aug 04, 2025 13 days

Trademark Image

ELASTATHERAPY

Basic Information

Serial Number
98391875
Filing Date
February 5, 2024
Published for Opposition
December 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Feb 4, 2025
Application
Pending
Classes
005

Rights Holder

Allergan Pharmaceuticals International Limited

99
Address
Clonshaugh Business & Technology Park
Dublin 17 D17E400
IE

Ownership History

Allergan Pharmaceuticals International Limited

Original Applicant
99
Dublin 17 IE

Allergan Pharmaceuticals International Limited

Owner at Publication
99
Dublin 17 IE

Legal Representation

Attorney
Cheryl A. Withycombe

USPTO Deadlines

Next Deadline
13 days remaining
NOA E-Mailed - SOU Required
Due Date
August 04, 2025
Extension Available
Until February 04, 2026

Application History

14 events
Date Code Type Description Documents
Feb 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 12, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 29, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 5, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations

Classification

International Classes
005